Kentucky Association of Diabetes Educators

Calendar Of Events

February 21st, 2012 ^Top

KADE LNG Feb 21 2012 CE Program & Meeting
5:30 am - 8:00 am
Optimizing the Use of Insulin to Improve the Management of Type 2 Diabetes
A CME/CPE/CE-Certified Workshop Series in Collaboration With State Coordinating Bodies of the American Association of Diabetes Educators

To register for this activity, please click here, or go to www.veritasime.com and enter activity code DIA1.

Date:	February 21, 2012
Dinner:	5:30 PM – 6:00 PM
Scientific Session:	6:00 PM – 8:00 PM
Location:	Malone's Banquets, Second Floor 3373 Tates Creek Road Lexington, Kentucky 40502

Sponsorship and Support
Sponsored by Veritas Institute for Medical Education, Inc.
Supported by an educational grant from sanofi-aventis U.S.

Dear Colleague:

The KADE Local Networking Group of the American Association of Diabetes Educators is pleased to invite you to the CME/CE activity, Optimizing the Use of Insulin to Improve the Management of Type 2 Diabetes. This workshop is part of a series sponsored by Veritas Institute for Medical Education, Inc., in conjunction with State Coordinating Bodies of the American Association of Diabetes Educators (AADE).

Program Overview
Clinicians confronting the rising epidemic of type 2 diabetes have the benefit of a diverse and well-stocked armamentarium to help patients manage their disease. One of the most effective treatments to control HbA1c is insulin. However, both clinicians and patients may view the use of insulin as a sign of treatment failure. This view is troubling, especially as evidence mounts that early use of insulin can be beneficial in achieving and maintaining appropriate blood glucose levels and avoiding the many diabetes-related complications. In addition, new insulin delivery systems make the process of self-medication considerably more convenient and comfortable.

To help clinicians determine which patients are candidates for insulin, when they should receive it, and how they can best incorporate insulin therapy into their lives, this workshop provides in-depth education, hands-on experience with several insulin delivery devices, and reinforced learning.

We hope you will participate in this valuable and practical activity.

Sincerely,

Faculty Co-chairs
Linda Siminerio, RN, PhD, CDE		Joseph Tibaldi, MD
Executive Director		Assistant Clinical Professor of Medicine
University of Pittsburgh Diabetes Institute		Albert Einstein College of Medicine
Pittsburgh, Pennsylvania		Bronx, New York
		Director, Endocrinology
		Flushing Hospital Medical Center
		Flushing, New York

Distinguished Faculty Presenters for This Workshop
Joan K. Bardsley, RN, MBA, CDE		Joseph Tibaldi, MD
AVP, Core Services		Assistant Clinical Professor of Medicine
Medstar Health Research Institute		Albert Einstein College of Medicine
Hyattsville, Maryland		Bronx, New York
		Director, Endocrinology
		Flushing Hospital Medical Center
		Flushing, New York

Intended Audience
The intended audience for this activity consists of primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other health care professionals who manage patients with type 2 diabetes.

Learning Objectives
At the conclusion of this activity, you should be better able to:

Select patients with type 2 diabetes who will benefit from insulin therapy, bearing in mind research demonstrating the positive impact on outcomes associated with early initiation of this treatment
Evaluate clinician and patient barriers to insulin treatment and methods to overcome these barriers
Formulate individualized treatment plans for patients requiring insulin that include which insulin-delivery device would best achieve the patient’s blood-glucose and A1C goals
Describe recent progress in insulin-delivery methods and the potential role of these technological advances in helping patients with type 2 diabetes

Workshop Agenda

Time		Topic
5:30 PM – 6:00 PM		Dinner
6:00 PM – 6:05 PM		Introduction and pretest
6:05 PM – 6:50 PM		Insulin: Advantages of Early Insulin Initiation
6:50 PM – 7:20 PM		Unraveling the Myths and Realities of Insulin Optimization
7:20 PM – 7:45 PM		Workshop
7:45 PM – 8:00 PM		Q & A and posttest

Accreditation Statement/Designation of Credit Statements
Veritas Institute for Medical Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians
Veritas Institute for Medical Education, Inc. designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

Veritas Institute for Medical Education, Inc. approved as a provider for nurse practitioner continuing education by the American Academy of Nurse Practitioners: AANP Provider Number 040309. This program has been approved for 2.0 contact hours of continuing education (which includes 2.0 hours of pharmacology).

Nurses
Veritas Institute for Medical Education, Inc. approved by the California Board of Registered Nursing, Provider #13986 for 2.0 Contact Hours.

Dietitians
This program has been approved by the Commision on dietetic Registration for 2.0 CPEUs.

Pharmacists

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare

AKH Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity is approved for 2.0 contact hours (0.2 CEUs). UAN 0077-9999-11-039-L04-P. Initial Release date September 8, 2011.

Criteria For Success
Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form.

Financial and Off-Label/Investigational Uses of Drugs/Medical Devices Disclosure Statement
The relevant financial relationships of those persons in a position to control the content of this CME/CE activity will be disclosed prior to the start of the educational activity. Participants are advised that this CME/CE activity will not contain references to medication or medical device names which at present are not FDA-approved for the treatment of patients with type 2 diabetes.

Americans With Disabilities Act
Veritas Institute for Medical Education, Inc. fully complies with the legal requirements of the Americans With Disabilities Act and the rules and regulations thereof.
If you are in need of any specific accommodation, please notify Rachel Moss at (201) 727-1115, ext. 2346 in order to receive service.

There is no fee for this activity.

To register for this activity, please click here, or go to www.veritasime.com and enter activity code DIA1.

If you do not wish to receive further e-mail solicitations from Veritas Institute, please e-mail
info@veritasime.com

Veritas Institute for Medical Education Inc.
611 Route 46 West
Hasbrouck Heights, NJ 07604

RSVP to this event